These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36852684)

  • 1. Bioinformatics and cheminformatics approaches to identify pathways, molecular mechanisms and drug substances related to genetic basis of cervical cancer.
    Andalib KMS; Rahman MH; Habib A
    J Biomol Struct Dyn; 2023; 41(23):14232-14247. PubMed ID: 36852684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical Cancer.
    Reza MS; Harun-Or-Roshid M; Islam MA; Hossen MA; Hossain MT; Feng S; Xi W; Mollah MNH; Wei Y
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for Cervical Cancer: A Bioinformatics Analysis.
    Qiu HZ; Huang J; Xiang CC; Li R; Zuo ED; Zhang Y; Shan L; Cheng X
    Technol Cancer Res Treat; 2020; 19():1533033820980112. PubMed ID: 33302814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potential crucial genes and key pathways shared in Inflammatory Bowel Disease and cervical cancer by machine learning and integrated bioinformatics.
    Nguyen TB; Do DN; Nguyen-Thi ML; Hoang-The H; Tran TT; Nguyen-Thanh T
    Comput Biol Med; 2022 Oct; 149():105996. PubMed ID: 36049413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer.
    Wu B; Xi S
    BMC Cancer; 2021 Jun; 21(1):733. PubMed ID: 34174849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
    Wu B; Xi S
    BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidating the molecular mechanisms of pterostilbene against cervical cancer through an integrated bioinformatics and network pharmacology approach.
    Li X; Yu D; Wang Q; Chen Y; Jiang H
    Chem Biol Interact; 2024 Jun; 396():111058. PubMed ID: 38761877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Key Genes and Pathways in Cervical Cancer by Bioinformatics Analysis.
    Wu X; Peng L; Zhang Y; Chen S; Lei Q; Li G; Zhang C
    Int J Med Sci; 2019; 16(6):800-812. PubMed ID: 31337953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Hub Genes as Potential Prognostic Biomarkers in Cervical Cancer Using Comprehensive Bioinformatics Analysis and Validation Studies.
    Xue H; Sun Z; Wu W; Du D; Liao S
    Cancer Manag Res; 2021; 13():117-131. PubMed ID: 33447084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying possible hub genes and biological mechanisms shared between bladder cancer and inflammatory bowel disease using machine learning and integrated bioinformatics.
    Liu J; Wu P; Lai S; Wang J; Wang J; Zhang Y
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16885-16904. PubMed ID: 37740761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of
    Zang Y; Zhao R; Wang T; Gao Y; Chen L; Liu S; Wang Y; Xue F
    Mol Med Rep; 2023 Jun; 27(6):. PubMed ID: 37114556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive identification of potential molecular targets and small drugs candidate for melanoma cancer using bioinformatics and network-based screening approach.
    Khan DA; Adhikary T; Sultana MT; Toukir IA
    J Biomol Struct Dyn; 2024 Sep; 42(14):7349-7369. PubMed ID: 37534476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis.
    Vastrad B; Vastrad C; Tengli A; Iliger S
    Arch Gynecol Obstet; 2018 Jan; 297(1):161-183. PubMed ID: 29063236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring Prognostic Biomarkers of Acute Myeloid Leukemia to Determine Its Most Effective Drugs from the FDA-Approved List through Molecular Docking and Dynamic Simulation.
    Alom MM; Faruqe MO; Molla MKI; Rahman MM
    Biomed Res Int; 2023; 2023():1946703. PubMed ID: 37359050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.